157 related articles for article (PubMed ID: 30202226)
1. Novel in-situ gel for intravesical administration of ketorolac.
Sherif AY; Mahrous GM; Alanazi FK
Saudi Pharm J; 2018 Sep; 26(6):845-851. PubMed ID: 30202226
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
3. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
[TBL] [Abstract][Full Text] [Related]
4. In situ gelling system for sustained intraarticular delivery of bupivacaine and ketorolac in sheep.
Abdeltawab H; Bolam SM; Jaiswal JK; McGlashan SR; Young SW; Hill A; Svirskis D; Sharma M
Eur J Pharm Biopharm; 2022 May; 174():35-46. PubMed ID: 35364255
[TBL] [Abstract][Full Text] [Related]
5. Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels.
Li X; Du L; Chen X; Ge P; Wang Y; Fu Y; Sun H; Jiang Q; Jin Y
Int J Pharm; 2015 Jul; 489(1-2):252-60. PubMed ID: 25957699
[TBL] [Abstract][Full Text] [Related]
6. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
7. Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine.
Jethava JK; Jethava GK
Int J Pharm Investig; 2014 Oct; 4(4):226-32. PubMed ID: 25426444
[TBL] [Abstract][Full Text] [Related]
8. Chitosan/β-glycerophosphate
Kolawole OM; Lau WM; Khutoryanskiy VV
Int J Pharm X; 2019 Dec; 1():100007. PubMed ID: 31517272
[TBL] [Abstract][Full Text] [Related]
9. Tailored Doxycycline Hyclate Loaded In Situ Gel for the Treatment of Periodontitis: Optimization, In Vitro Characterization, and Antimicrobial Studies.
Ranch KM; Maulvi FA; Koli AR; Desai DT; Parikh RK; Shah DO
AAPS PharmSciTech; 2021 Feb; 22(3):77. PubMed ID: 33595740
[TBL] [Abstract][Full Text] [Related]
10. Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan.
Li C; Li C; Liu Z; Li Q; Yan X; Liu Y; Lu W
Int J Pharm; 2014 Oct; 474(1-2):123-33. PubMed ID: 25138250
[TBL] [Abstract][Full Text] [Related]
11. Design, Characterization and Pharmacokinetic-Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma.
Rawat PS; Ravi PR; Mir SI; Khan MS; Kathuria H; Katnapally P; Bhatnagar U
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839727
[TBL] [Abstract][Full Text] [Related]
12. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.
Abdeltawab H; Svirskis D; Sharma M
Expert Opin Drug Deliv; 2020 Apr; 17(4):495-509. PubMed ID: 32067500
[No Abstract] [Full Text] [Related]
13. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
El Maghraby GM; Elzayat EM; Alanazi FK
Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
[TBL] [Abstract][Full Text] [Related]
14. Injectable In Situ Gelling System for Sustained Nicotine Delivery as a Replacement Therapy for Smoking Cessation.
Hulambukie E; Abdeltawab H; Duarah S; Svirskis D; Sharma M
Gels; 2022 Feb; 8(2):. PubMed ID: 35200495
[TBL] [Abstract][Full Text] [Related]
15.
Hemelryck SV; Dewulf J; Niekus H; van Heerden M; Ingelse B; Holm R; Mannaert E; Langguth P
Int J Pharm X; 2019 Dec; 1():100016. PubMed ID: 31517281
[TBL] [Abstract][Full Text] [Related]
16. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
17. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
18. Injectable thermoresponsive gels offer sustained dual release of bupivacaine hydrochloride and ketorolac tromethamine for up to two weeks.
Abdeltawab H; Svirskis D; Boyd BJ; Hill A; Sharma M
Int J Pharm; 2021 Jul; 604():120748. PubMed ID: 34051318
[TBL] [Abstract][Full Text] [Related]
19. Formulation development, optimization, and in vitro assessment of thermoresponsive ophthalmic pluronic F127-chitosan
Modi D; Mohammad ; Warsi MH; Garg V; Bhatia M; Kesharwani P; Jain GK
J Biomater Sci Polym Ed; 2021 Sep; 32(13):1678-1702. PubMed ID: 34013840
[TBL] [Abstract][Full Text] [Related]
20. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
